Literature DB >> 17768440

Treatment of large and giant residual and recurrent vestibular schwannomas.

Ricardo Ramina1, Maurício Coelho Neto, Kelly Cristina Bordignon, Tobias Mattei, Rogério Clemente, Paulo Henrique Pires Aguiar.   

Abstract

This report is a retrospective analysis of the surgical outcome of 15 patients (8 females, 7 males; mean age, 37.8 years) with residual or recurrent vestibular schwannomas operated on between 1987 and 2005. These 15 patients were part of a larger series of 252 consecutive vestibular schwannoma excisions. Tumors were classified as large (10) when their diameter exceeded 3.5 cm and giant (5) when their diameter exceeded 4.5 cm. All patients had previously undergone surgery. Hearing was lost in all cases, 8 had complete facial nerve palsy, 6 had trigeminal nerve deficits, 5 had cranial nerve IX and X palsy, and 10 had ataxic gait. Twelve patients had hydrocephalus. The tumors were reoperated through the retrosigmoid-transmeatal approach. The mean postoperative follow-up was 4.9 years. Complete resection was achieved in all patients. The facial nerve was preserved in 6 of the 7 patients with preoperative facial function. Transient worsening of bulbar cranial nerves palsy occurred in 2 cases. Cerebrospinal fluid leakage occurred in 3 patients. There were no deaths, and the tumors were histologically benign. Surgical removal is the only treatment for these lesions. Total resection associated with a low morbidity rate is possible. Preservation of the facial nerve is difficult due to severe scar tissue.

Entities:  

Year:  2007        PMID: 17768440      PMCID: PMC1876156          DOI: 10.1055/s-2006-953510

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  19 in total

1.  Recurrence of acoustic neuroma after incomplete resection.

Authors:  H K El-Kashlan; H Zeitoun; H A Arts; J T Hoff; S A Telian
Journal:  Am J Otol       Date:  2000-05

2.  Acoustic neuroma recurrence after suboccipital resection: management with translabyrinthine resection.

Authors:  J B Roberson; D E Brackmann; W E Hitselberger
Journal:  Am J Otol       Date:  1996-03

3.  [Recurrent acoustic neurinoma after complete surgical resection].

Authors:  J M Thomassin; W Pellet; J P Epron; F Braccini; P H Roche
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  2001-02

Review 4.  Acoustic neuromas: results of current surgical management.

Authors:  W B Gormley; L N Sekhar; D C Wright; D Kamerer; D Schessel
Journal:  Neurosurgery       Date:  1997-07       Impact factor: 4.654

5.  Risk factors for neurological complications after acoustic neurinoma radiosurgery: refinement from further experiences.

Authors:  K Ito; M Shin; M Matsuzaki; K Sugasawa; T Sasaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

6.  Vestibular schwannomas and auditory function: options in large T3 and T4 tumors?

Authors:  C Matthies; M Samii
Journal:  Neurochirurgie       Date:  2002-12       Impact factor: 1.553

7.  Residual and recurrent acoustic neuromas.

Authors:  C W Beatty; M J Ebersold; S G Harner
Journal:  Laryngoscope       Date:  1987-10       Impact factor: 3.325

8.  The fate of the tumor remnant after less-than-complete acoustic neuroma resection.

Authors:  Dov C Bloch; John S Oghalai; Robert K Jackler; Monica Osofsky; Lawrence H Pitts
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

9.  Unilateral acoustic tumors: how often do they recur after translabyrinthine removal?

Authors:  C Shelton
Journal:  Laryngoscope       Date:  1995-09       Impact factor: 3.325

10.  Radiosurgery of residual and recurrent vestibular schwannomas.

Authors:  F Unger; C Walch; G Papaefthymiou; K Feichtinger; M Trummer; G Pendl
Journal:  Acta Neurochir (Wien)       Date:  2002-07       Impact factor: 2.216

View more
  9 in total

1.  Staging in vestibular schwannoma surgery: a modified technique.

Authors:  Ealmaan Kim; Sung-Il Nam
Journal:  J Korean Neurosurg Soc       Date:  2008-01-20

2.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

3.  Critical remarks on the proposed "extended retrosigmoid approach".

Authors:  Tobias Alecio Mattei; Ricardo Ramina
Journal:  Neurosurg Rev       Date:  2011-06-30       Impact factor: 3.042

4.  Management of large and giant vestibular schwannomas.

Authors:  Irumee Pai; James Bowman; Nick Thomas; Neil Kitchen; Anthony Strong; Rupert Obholzer; Michael Gleeson
Journal:  Skull Base       Date:  2011-11

5.  Clinical features, microsurgical treatment, and outcome of vestibular schwannoma with brainstem compression.

Authors:  Ali Harati; Kai-Michael Scheufler; Rolf Schultheiss; Albaraa Tonkal; Kamran Harati; Paul Oni; Thomas Deitmer
Journal:  Surg Neurol Int       Date:  2017-04-05

6.  Risk Factors for Progression in Vestibular Schwannomas After Incomplete Resection: A Single Center Retrospective Study.

Authors:  Jiuhong Li; Xueyun Deng; Daibo Ke; Jian Cheng; Si Zhang; Xuhui Hui
Journal:  Front Neurol       Date:  2021-11-26       Impact factor: 4.003

7.  Staging in giant vestibular schwannoma surgery: A two consecutive day technique for complete resection in basic neurosurgical setups.

Authors:  Deepak Bandlish; Nilay Biswas; Sumit Deb
Journal:  J Neurosci Rural Pract       Date:  2014-07

8.  Is staged surgery for giant vestibular schwannomas always better in improving outcome: Needs socioeconomic consideration?

Authors:  Guru Dutta Satyarthee; Sushil Kumar
Journal:  J Neurosci Rural Pract       Date:  2014-10

9.  Preserving normal facial nerve function and improving hearing outcome in large vestibular schwannomas with a combined approach: planned subtotal resection followed by gamma knife radiosurgery.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Marc Levivier
Journal:  Acta Neurochir (Wien)       Date:  2017-05-17       Impact factor: 2.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.